A 24-year-old shared three months of progress using dutasteride, minoxidil, and biotin for hair loss. The post includes progress pictures and discusses the effectiveness of these treatments.
The user experienced hair regrowth using a chewable combination of oral minoxidil and finasteride without side effects, unlike when taken separately. The treatment is from Hims, and the user is satisfied with the progress, especially on the crown.
A 30-year-old is considering starting hair regrowth treatments and is seeking advice on medications like minoxidil and finasteride, as well as other therapies. Users suggest starting with the "big 4" treatments and share that many have seen success even when starting later in life.
A 26-year-old male shared progress photos showing hair improvement after nearly 5 months on oral Minoxidil (4mg), Dutasteride (0.5mg), and biotin (4mg). The photos show noticeable hair growth over time.
Actifolic RU-58841 powder and GhK-Cu peptide were tested and found to be accurate. The user is satisfied with the product's authenticity for hair loss treatment.
User shared progress pictures after 3 months of using 1mg finasteride, 5% minoxidil, a dermaroller, and castor oil. They humorously commented on their results.
A group buy for products to treat hair loss, such as Minoxidil, Finasteride and RU58841. Participants are interested in adding more people before ordering the next order.
A 34-year-old man has been using oral minoxidil and finasteride for three months with noticeable hair regrowth and no side effects. He is considering a hair transplant but is currently satisfied with the progress and prefers not to switch to more aggressive treatments.
A user shared their 9-month progress using RU58841 at 2% daily for hair regrowth, initially starting at 5% but reducing the dose due to early signs of gynecomastia, which has since mostly resolved. They achieved their goal of regrowing hair at the temples and hairline.
The conversation discusses various hair loss treatments, including minoxidil, finasteride, dutasteride, pyrilutamide, alfatrodial, and nizoral, with a focus on the potential of new treatments like gt20029 and breezula. There is optimism about novel treatments that don't have systemic effects, although skepticism remains about the effectiveness of some new drugs.